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ABSTRACT  Neosaxitoxin  (neoSTX)  differs  structurally  from saxitoxin  (STX)  in 
that the hydrogen on N-1  is replaced by a hydroxyl group. On single frog skeletal 
muscle fibers in the vaseline-gap voltage clamp, the concentrations for reducing the 
maximum  sodium  current  by  50%  (EDs0) at  pH's  6.50,  7.25,  and  8.25  are, 
respectively, 4.9, 5.1, and 8.9 nM for STX and  1.6, 2.7, and  17.2 nM for neoSTX. 
The  relative  potencies  of STX  at  the  different  pH's  closely  parallel  the  relative 
abundance  of the  protonated  form  of the  7,8,9  guanidinium  function,  but  the 
relative potencies of neoSTX at the same pH's vary with the relative abundance of 
the  deprotonated  N-1  group.  In  constant-ratio  mixtures  of the  two  toxins,  the 
observed EDs0's are consistent with the notion that the two toxins compete for the 
same  site.  At  pH's  6.50  and  7.25,  the  best  agreement  between  observed  and 
computed values is obtained when the efficacy term (c) for either toxin is  1. At pH 
8.25  the best agreement is obtained if the efficacy is  1 for STX but 0.75  for neo- 
STX. The marked pH dependence of the actions of neoSTX probably reflects the 
presence of a  site  in the receptor that interacts with the  N-1  -OH, in addition  to 
those  interacting  with  the  7,8,9  guanidinium  and  the  C-12  hydroxyl  groups. 
Considering the three-dimensional structure of the STX and neoSTX molecules, the 
various site points are probably located in a fold or a crevice of the channel protein, 
where the extracellular orifice of the sodium channel is located. 
INTRODUCTION 
Saxitoxin (STX) is an important neurobiological tool because of its high affinity and 
high  specificity binding  to voltage-gated  sodium  channels  of many excitable  mem- 
branes.  Recent studies suggest that its binding site is located near the external orifice 
of the sodium channel (Kao and Walker,  1982; Kao,  1983; see also Moczydlowski et 
al.,  1984a; Strichartz,  1984), rather than some distance into the channel itself (Hille, 
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1975).  However, an alternative view is that the binding site is not in the permeation 
path  of the  channel  (Green  et  al.,  1987).  As  the  primary  structure  of the  sodium 
channel is known (Noda et al.,  1984),  a better understanding of the binding of STX 
to  its  receptor  could  help  to  locate  the  site  and  provide  a  landmark  on  the  large 
protein molecule to aid further structural clarification. 
In the  absence  of a  covalent marker for this  site,  a  useful  approach  is  to deduce 
complementary requirements  in the binding site from structure-activity  relations  of 
the toxin molecules (see summary in Kao, 1986). Of the two guanidinium functions in 
STX, the 7,8,9 group has been identified as the active group involved in blocking the 
sodium  channel  (Kao  et  al.,  1983).  The  role  of the  1,2,3  guanidinium  group  is 
unclear,  but it was not believed to be involved in channel blockade (Kao and Walker, 
1982; Kao,  1983;  Kao et al.,  1983).  Neosaxitoxin  (neoSTX) differs structurally from 
STX  only in  having  the  hydrogen  on  N-1  replaced  by a  hydroxyl  (Shimizu  et  al., 
1978; Koehn et al.,  1981),  and therefore could be useful for probing the role of the 
1,2,3 group. 
Previous  studies  on neoSTX  showed  that  at acidic  and  neutral  pH's it was  about 
equally as potent as STX, but that at alkaline pH's it was markedly and unexpectedly 
weaker than STX (Kao et al.,  1983).  Strichartz  (1984) confirmed the low potency of 
neoSTX in alkaline conditions, but reported that under acidic and neutral conditions 
it was  much more  potent  than  STX.  Largely on the  basis  of these  observations,  he 
proposed  a  covalent  reaction  between  the  C-12  -OH's  of these  toxins  with  some 
groups  in  the  receptor  as  the  basis  of their  binding.  However,  this  proposal  is  at 
variance  with  key  chemical  information,  because  derivatives  of STX  (Koehn  et  al., 
1981) and of neoSTX (Wichmann,  1981) where the C-12 groups have been reduced 
to alcohol configurations and cannot form covalent bonds are still active (Wichmann, 
198 l; Koehn et al.,  1981; Kao et al.,  1985). In the course of re-examining the actions 
of neoSTX, we found evidence that the N-1 group probably participates in binding to 
the channel protein.  This information strongly implies  certain  structural  features  of 
the receptor site that had not been suspected before. 
Preliminary accounts of this information have appeared  (Hu and Kao,  1986; Kao, 
1986). 
MATERIALS  AND  METHODS 
These experiments were done on short segments of single fibers of the semitendinosus muscle 
of the English frog Rana temporaria, using the vaseline-gap voltage clamp method (Hille  and 
Campbell,  1976).  In these experiments,  an internal  solution containing potassium glutamate 
and  EGTA (see  below)  was  applied  in the end  pools instead  of the  CsF used  by Hille  and 
Campbell.  These  EGTA-treated  fiber  segments  did  not  contract  upon  depolarization.  All 
experiments were carried out at room temperature,  ~ 22°C. 
In all  experiments  the fibers were held at  -90 mV.  Leakage and capacitive currents were 
compensated for by using an analog circuit.  Fibers were discarded when the leakage current 
became unstable. Depolarizing steps of 10-mV increments were applied until  ~ 20 mV beyond 
the reversal potential of the initial  current. Current traces around the maximum Is  a and around 
ENd were recorded; the maximum INn was used to compare the actions of toxins, and the current 
at ENa (IK) was used for assessing the health of the fiber as well as for checking the selectivity of 
action of the toxins on  /Na"  No corrections were made to compensate for the series  resistance. 
In the presence of an uncompensated series resistance, the voltage control during the flow of Hu AND KAO  NeoSTX and STX Binding Sites  563 
large membrane currents could be inaccurate, but the error would decrease as INa was reduced 
when increasingly higher concentrations of toxins were applied. A small systematic error could 
exist in the steepness of the dose-response curves.  However,  the EDs0 was not affected. This 
point was tested in a  small series of fibers as follows: A  concentration of neoSTX close to the 
EDs0 was tested on two groups of fibers, one in the usual Ringer's solution containing 110 mM 
Na ÷ and the other in a  modified Ringer's solution containing 40 mM Na + and 70 mM choline 
chloride. The average density oflN~ before toxin was 3.9 mA cm -2 in  110 mM Na ÷ and 1.7 mA 
cm -2 in 40 mM Na ÷. Since the EDs0 for neoSTX at pH  7.25 was 2.7 nM (see Results), 3.0 nM 
was applied. The IN~ normalized to the pretoxin value was 43.3  --- 2.7% (means --- SEM, n  =  8) 
for fibers in  110 mM Na ÷ and 45.9  ___ 4.3% (n =  11) for fibers in 40 mM Na ÷. The difference 
between the means is statistically insignificant. 
Any influence of shifts of the I-V relations along the voltage axis that occurred upon toxin 
action was circumvented by experimentally finding the maximum lNa under all conditions (see 
also Wagner and Ulbricht, 1975). For any individual fiber, the Esa remained constant to within 
5  mV throughout the experiment. 
The Ringer's solution bathing the fiber exterior consisted of (in mM/liter):  110 Na ÷, 2.5 K ÷, 
1.8 Ca  2÷, 116.3 CI-, and 5 HEPES. The pH was adjusted to 6.50, 7.25, or 8.25 with NaOH. The 
internal solution consisted of 115 K ÷,  5  Na +,  115 glutamate,  5  H2PO~  and 3  EGTA. The pH 
was adjusted to 7.4. 
The general procedure was to determine the maximum INa in toxin-free solutions as a  basis 
of comparison.  Then  various  concentrations  of toxins  were  introduced  until  a  steady-state 
reduction in the maximum INa was reached in each.  It should be noted that at the voltage at 
which maximum IN~ was elicited, I K was small and developing so gradually that at the time INa 
peaked (~ 0.7 ms) no detectable 1 K had developed (Fig.  1). Therefore, even with the potassium 
conductance intact in the fibers used, there is little error in our assay that can be attributed to 
an overlap of the sodium and potassium currents. 
From such observations, dose-response relations were constructed based on the normalized 
residual maximum 1N, (l~a/INa). Each  individual fiber could be used for three or four trials in 
increasing concentrations of toxins without a  need for recovery  in  between.  In most cases  a 
washout and recovery were obtained at the end to make certain that the observed toxin effects 
were reversible. Generally,  15 rain was allowed for the washout, by the end of which 80-90% of 
the pretoxin  maximum  IN~ has recovered.  The recovery of IN~ followed  an exponential time 
course  with  a  time  constant  of  ~  1  min.  At  10  min  the  recovery  was  virtually  complete; 
lengthening the washout period to 40 min did not appreciably increase the degree of recovery. 
These observations suggest that the toxin effects observed in the present experiments were due 
primarily to the sodium channels in the sarcolemma,  and that any contribution from sodium 
channels in the transverse tubules was minor. The degre of recovery varied, influenced in part 
by the concentration of toxin used. We found tetrodotoxin (T-YX,  Hebei preparation, Hu and 
Kao,  1985;  available from Calbiochem Corp.,  San Diego,  CA) to be the most fully reversible, 
with recoveries  of 90-100%;  recovery  from  STX was  slightly  less  complete,  ~90%,  whereas 
recovery from neoSTX was least complete,  ~ 75%. 
The toxin concentrations chosen embraced the central portions of the dose-response curve 
on both sides of the inflection point.  Usually,  the same concentrations were used at different 
pH's  so that the results could be compared  statistically.  In some cases, additional concentra- 
tions were used to cover extended portions of the curve. The toxin effects were also shown in 
Hill plots, in which log (1  -  P)/P(P = l~fllNa)was plotted against log [toxin]. The results were 
fitted by least-squares linear regression lines, with very good fit in every case. The EDs0's were 
determined  from  these  plots  when  (1  -  P)/P  =  1.  Standard  errors  of estimates  were  also 
obtained from the regression analysis. Tests of significance of differences between means were 
performed on the basis of these standard errors (Arkin and Colton,  1953). At (1  -  P)/P =  1, the H
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standard errors of estimate covered a  concentration range equivalent to  -+ 1 SD of the EDs0. 
The  standard  error  of  the  mean  of  the  ED~0's, as  listed,  was  one-half  of  the  covered 
concentration ranged divided by the square root of the number of samples. 
The experiments on interactions between STX and neoSTX were done at pH's of 6.50 and 
8.25, because at these pH's differences in the actions of the two toxins were the largest within 
the physiological range of pH in which we were interested (see Results). At each pH the fibers 
were treated sequentially with a  mixture of the two toxins in increasing concentrations. The 
mixture was made up such that the ratio of the concentrations of the two toxins (et =  [T2]/[T~]  ) 
closely matched the ratio of their individual EDs0's (r  =  EDs0.2/EDs0a). Dose-response curves 
were constructed from normalized maximum IN, in a mixture as a function of the concentration 
of the more potent toxin. The theoretical potencies of such mixtures based on the assumption 
of two toxins acting on the same site or two toxins acting on different sites were calculated 
according to relations developed previously (Ariens et al., 1964; Kao and Walker, 1982).  These 
computed potencies were compared with the observed potencies obtained from the regression 
lines in the Hill plots. 
RESULTS 
To  facilitate the  following presentation, we  first restate briefly the  salient chemical 
properties of STX and neoSTX. The N- 1 of neoSTX (Fig. 1) deprotonates with a pK~ 
of 6.75 (Shimizu et al., 1978). The pK~ of the 7, 8, 9  guanidinium in STX is 8.25 and 
that  in  neoSTX  is  8.65,  whereas  the  pK~  of  the  1,  2,  3  guanidinium  in  both 
compounds is  >  11  (Rogers and Rapoport,  1980; Schantz et al., 1975; Shimizu et al., 
1981).  The C-12  -OH  groups in STX are in a  gem-diol configuration (HO-C-OH, 
hydrated  ketone) which  exists  in  equilibrium with  the  unhydrated  ketone  (C =  O, 
carbonyl form). At pH 7 they are almost all in the gem-diol form; at pH 7.8, 76% is in 
this form,  the fraction declining in more alkaline conditions (Shimizu et al.,  1981). 
Deuterium  or tritium can be exchanged  from  the solvent onto the C-11  methylene 
through a ketone-enol tautaumerism at C-12 (Rogers and Rapoport,  1980). The rate 
of exchange is apparently faster in neoSTX than in STX (Shimizu et al., 1981). There 
is, however, no quantitative information on any details of the ketone-ketone hydrate 
equilibrium in neoSTX similar to that for STX. The two guanidinium functions are in 
a purine nucleus, and are placed at  ~  130  ° to each other (see perspective view in Fig. 
8; see also Kao and Walker,  1982;  Kao,  1983). 
STX 
As a basis for comparison with neoSTX, the effects of STX are shown in Fig. 1. As the 
INa was reduced,  the IK remained virtually the same through four different doses of 
STX. From records like these, dose-response relations were constructed at pH's 6.50, 
Figure  1. (opposite)  Current records from two individual fibers treated with different concen- 
trations  of STX  and  neoSTX  at  pH  7.25.  Holding potential for  each  fiber was  -90  mV. 
Temperature was ~ 22°C.  Largest current in each panel was maximum INa- Note that at voltage 
and  time  of maximum  INa, no  I F was yet detectable.  Note  also  the  stability of I F and  the 
specificity of toxins for IN~. Inset shows structures of STX and neoSTX. Difference is on N-l, 
with -H in STX and -OH in neoSTX, pKa's for 7, 8, 9 guanidinium are 8.25 for STX and 8.65 
for neoSTX; pKa for 1, 2, 3 guanidinium is > 11; and pKa for N-I  -OH  in neoSTX is 6.75. 566  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  97  •  1991 
7.25,  and 8.25  (Fig.  2 A). The observations were also displayed in a  Hill plot of log 
(1  -  P)/P  vs. log concentration (Fig.  2 B). These pH's were selected because of their 
relation to key chemical properties of the STX and neoSTX molecules, 6.50 being on 
the acid side of the pK, of N-I -OH  in neoSTX, and 8.25 being the pK, of the 7, 8, 9 
guanidinium  of STX.  pH's 7.25  and  8.25  have also been used  in  a  previous study 
(Kao et al.,  1983),  with which  some of the present results might be compared.  No 
other pH's were  studied,  because at  pH's lower than  6.50  proton blockade of the 
sodium  channel  can  be  expected  (e.g.,  Hille,  1984),  whereas  at  pH's  above  8.8 
chemical degradation of STX and neoSTX would intervene. 
The EDs0's of STX at pH's 6.50,  7.25,  and 8.25  are, respectively, 4.9  _+  0.2  (51), 
5.1  -+ 0.2 (31), and 8.9 +  0.4 (58) nM (means -+ SEM followed by number of samples 
in parentheses). Confirming previous observations, the dose-response curves can be 
readily fitted with a  theoretical  bimolecular scheme with  an exponent close to  1.0. 
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FIGURE 2.  Dose-response relations of STX at different pH's. (A) Normalized residual maxi- 
mum INa VS. [STX]. Points  are means -  SEM, with attached number showing fibers used for 
each point. Solid lines are drawn  according to a bimolecular reaction scheme where I~a/INa  = 
1 -- 1/(1  +  EDs0/[toxin]). (B) Hill plot of same data, log (1  -  P/P)  vs. log [STX], where P  = 
l~a/1Na.  Lines are drawn  by least-squares  linear regression. Slopes  of lines are  1.25, 1.12, and 
1.09, respectively, for pH 6.50,  7.25, and 8.25. 
This feature is also seen in the Hill plots, where the slopes are  1.2,  1.1,  and  1.1  for 
pH's 6.50,  7.25,  and 8.25, respectively. 
The relative potencies of STX at pH's 7.25  and  8.25  is  1.75,  in close agreement 
with a  previous finding on the squid axon (1.79;  Kao et al.,  1983). This ratio is very 
close to the relative abundance  of the protonated  form of the  7,  8,  9  guanidinium 
(1.80),  reaffirming a  conclusion  that  the  7,  8,  9  group  is  involved in  blocking  the 
sodium channel. At pH 6.50,  98% of the 7, 8, 9 group is protonated, compared with 
90% at pH 7.25.  If the interaction of STX with the receptor depended  only on the 
abundance of the charged 7, 8, 9 guanidindium, one would have expected an EDs0 of 
4.7  nM  at pH  6.50.  The  observed  EDs0 of 4.9  nM  shows  that  at  pH  6.50  STX  is 
slightly less potent than at pH  7.25.  Although  the difference between the observed 
EDs0's  at  pH's  6.50  and  7.25  is  not  statistically  significant  (P  >  0.3),  a  similar 
observation has been made by a  number of investigators before  (e.g.,  Wagner and Hu AND KAO  NeoSTX and STX Binding Sites  567 
Ulbricht,  1975;  Barchi and Weigel,  1979;  Strichartz,  1984).  Such a  discrepancy also 
occurs for both neoSTX  and TI'X. A  plausible explanation  is that  at pH  6.50  the 
density of the negative surface charges is lower, resulting in a  reduced attraction of 
the positively charged STX to the binding site (e.g., Wagner and Ulbricht,  1975). 
neoSTX 
Like STX, neoSTX blocked only the IN~ (Fig.  1). The ED~0's of neoSTX determined 
from Fig. 3 are 1.6  -  0.1  (36), 2.7  --- 0.1  (42), and  17.2  +  0.6 (68) nM, respectively, 
for pH's 6.50,  7.25,  and  8.25.  Thus,  confirming Strichartz's  observation  (1984)  at 
near neutral or acidic pH's, we found that this sample of neoSTX was more potent 
than STX at pH 7.25 (see Discussion). That the relative potency of neoSTX to STX at 
pH's 6.50 and 7.25 reported here is less than one-half of that reported by Strichartz 
for frog nerve bundles may be attributed in part to the different tissues used, as the 
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FIGURE  3.  Dose-response relations of STX at different pH's. Conventions are the same as 
those in Fig. 2. (A) Normalized residual maximal INa vs. [neoSTX].  For better fit, curves were 
steepened with a power of ~ 1.4 in bimolecular scheme, but EDs0 is unaffected (see Kao and 
Walker,  1982). (B)  Hill  plot.  Slopes  of linear  regression  lines  are  1.41, 1.43, and  1.27, 
respectively,  for pH's 6.50,  7.25, and 8.25. 
sodium channels  in  muscle  and  nerve are different isoforms (Barchi,  1986;  Numa 
and Noda,  1986). 
At pH  8.25,  neoSTX was  appreciably less  potent  than  STX  on  the  frog muscle 
fiber,  as it was on the  squid  axon (Kao et al.,  1983)  and on the frog nerve bundle 
(Strichartz,  1984).  If the abundance of the protonated 7, 8, 9  guanidinium  function 
were the  only determinant  of potency,  neoSTX,  in which  the  pK~ of this  group is 
8.65, should have been ~ 20% more potent than STX. On the other hand, because its 
net charge changes  from + 1.6  to  +0.6  as pH changes from 6.5  to 8.25,  the  local 
concentration  of neoSTX at the binding  site could possibly decrease by a  factor of 
2.7,  thereby  affecting  its  potency  (see  below).  However,  the  observed  change  in 
potency by a  factor of 10.8  is far greater.  Therefore,  the  lowered  potency is most 
probably caused chiefly by the state of the N-1  -OH  in neoSTX. 
TTX 
Changes in pH can affect the density of negative surface charges and  any negative 
charge due to specific groups in the toxin-binding  site, which will in turn influence 568  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  97  •  1991 
the local concentration of the cationic toxin molecules. The possible effects of pH on 
surface charges can be calculated in several ways, using different assumptions. Here 
we adopt an experimental approach to this problem by examining the influence of 
pH on the binding of TI'X, in addition to those of STX and neoSTX.  It should be 
recalled  that  the  only guanidinium  function  in TI'X has  a  pKa of over  11,  and  is 
therefore almost all protonated within the physiological range of pH's. However, the 
C-10  -OH  of TI'X deprotonates with a  pK, of 8.8,  and could cause TI'X to occur 
predominantly  in  either a  cationic or  zwitterionic  form. Thus,  to help  resolve the 
question  of the influence  of surface charge on toxin  effects,  three  toxin  molecules 
with identical capabilities of blocking the Na + channel are available, with net charges 
from +1  (TI'X) to +2 (STX), and varying from +0.6 to +1.6 (neoSTX). 
The potency of TFX at pH's 6.50,  7.25,  and 8.25 on the frog skeletal muscle are 
shown in Fig. 4, where the EDs0's are 3.8  --+- 0.1  (43),  3.1  +  0.2  (17),  and 4.3  -+ 0.2 
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FIGURE 4.  Dose-response relations of TI'X at different pH's. Conventions are the same as 
those in Fig. 2. (A) Normalized residual maximal IN~ vs. [TTX]. Solid lines are drawn according 
to a biomolecular reaction scheme.  (B) Hill plot of the same data.  Linear regression fit gives 
slopes of 1.28, 1.21, and 1.26 for pH's 6.50,  7.25, and 8.25, respectively. 
(26) nM, respectively. The relative potency at 7.25 and 8.25 is 1.23, and the relative 
abundance of the C-10 -OH  at these pH's is 1.24. Similar to the observation on STX 
and neoSTX, at pH 6.50 T-FX is slightly less potent than expected (P  <  0.001). 
Effect of pH on Toxin Potencies 
In Fig. 5, the observed potencies ofTTX, STX, and neoSTX at pH's 6.50,  7.25,  and 
8.25  are  compared  with  those  that  might  be  expected  on  the  basis  of certain 
assumptions  of  the  chemical  states  of  the  toxin  molecules.  For  each  toxin,  the 
observed EDs0 at pH 7.25 was taken as the reference, and the expected potencies for 
other  pH's  were  calculated  from  it  on  the  basis  of  the  Henderson-Hasselbalch 
relation. For TFX, the expected potency is based on the degree of protonation of the 
C-10  -OH  function.  For STX and neoSTX, two different assumptions are used.  In Hu AND KAO  NeoSTX and STX Binding Sites  569 
one case, the expectation is based on the relative abundance of the protonated form 
of the 7, 8, 9 guanidinium.  It is evident that for STX the observed and the expected 
potencies are in dose agreement, whereas for neoSTX they are not.  For the latter, 
expected  potencies  were  also  calculated  on  the  basis  of  the  abundance  of  the 
deprotonated N-I -OH  group. Clearly, for neoSTX the observed pH dependence of 
potencies is in much closer agreement with the state of the N-1  -OH  group than it is 
with that of the 7, 8, 9  guanidinium. 
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FIGURE 5.  pH dependence  of potency of TI'X, STX,  and  neoSTX.  Solid  lines  and  filled 
circles are experimental results.  Dashed lines are toxin concentrations expected to cause 50% 
reduction of  maximum IN, computed on the basis of relative abundance of the protonated form 
of the C-10 hydroxyl group of'VI'X and of the 7, 8, 9 guanidinium group in STX and neoSTX. 
The concentration at pH 7.25 was used as reference, and those for other pH's were calculated 
on  the  basis  of applicable pK  a and  the  Henderson-Hasselbalch relation.  For neoSTX,  the 
broken line  represents expectation based on the abundance of deprotonated N-1  -OH. For 
each toxin, the  slight  discrepancy between observed and  expected potencies at pH 6.50  is 
probably due to a slight decrease in the density of surface negative charges. For neoSTX, the 
discrepancy at pH 8.25 may be caused by competition between active and inactive species of the 
neoSTX molecule (see Discussion). 
For each toxin molecule, it is worth noting  how well the observed and expected 
potencies coincide, even though the net charge on the molecule is rather different. 
These  observations  indicate  that  within  the  pH  range  of 6.50-8.25  there  is  little 
evidence that the surface charges were affected sufficiently to influence toxin binding 
in any substantial way. They also show that the important determinant of binding is 
the abundance of the active species of the molecule and not the net electric charge of 
the  whole  molecule  (Chabala,  L.,  and  O.  S.  Andersen,  personal  communication). 570  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  97  •  1991 
Therefore, our results can be interpreted in terms of how different states of the toxin 
molecules interact with basically the same receptor site. 
Interactions between  STX and neoSTX 
The apparent involvement of the N-1 group in affecting the potency of neoSTX but 
not STX prompted us to examine whether STX and neoSTX competed for the same 
binding site.  The  results  led  to  a  previousIy unexpected aspect  of the  binding of 
neoSTX to the receptor.  In these experiments,  constant ratio mixtures of STX and 
neoSTX were tested in the same way as single toxins had been. The procedures were 
modeled on those described in detail in Kao and Walker (1982). The expected ED~0's 
were computed for the cases where both toxins acted on the same binding site,  and 
where the two toxins acted on different sites.  The outcome was then compared with 
the experimental results. 
Figs. 6 and 7 show the dose-response relations of these experiments at pH's 6.50 
and 8.25, as compared with those of the single toxins. Table I shows the ratios of the 
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FIGURE 6.  Dose-response relations  of STX, neoSTX, and constant-ratio  mixtures  of the two 
toxins at pH 6.50. At this pH, N-1 -OH of neoSTX is mostly protonated with no charge. The 
data for single toxins are the same as those shown in Figs. 2 and 3. Assuming EDs0 = K, r  = 
K2/K  l =  3.58. Mixtures of toxins in a ratio of ~ 3.5 are: [STX]/[neoSTX] =  0.53 nM/0.15 nM; 
1.05/0.3; 2.1/0.6; 3.15/0.9+ The observed  EDw for the mixture  (as neoSTX  equivalent)  is in 
good agreement with the EDs0 computed for the two toxins competing for one site. 
concentrations of the toxins (et), and of their ED~0's (r) in the mixture, with the more 
potent toxin designated as T~ and the tess potent toxin as T~. The observed potency 
shown denotes  the  concentration of T~  in  the  mixture  that  is  required  to  half the 
maximum INa. Also shown are  the expected EDs0's for the case of single-site action 
and  that  for different-site  action.  For each  pH  the  observed  ED~0 is  closer  to  that 
expected of a single-site action by these two toxins than it is to that of a different-site 
action. 
It should be pointed out that the expected EDs0's calculated according to Eqs.  2 
and 3 in Kao and Walker (1982) are based on the assumption that the efficacy (e) of 
both STX and neoSTX is  1 (i.e.,  EDs0 =  Kd; see  Discussion).  For the results  at pH 
6.50, the close agreement (to within 2%) between the expected and observed EDs0's 
justified tOis assumption. For the results at pH 8.25, the observed EDs0 exceeds that 
expected by 32%,  a  discrepancy which suggests that the assumptions used were not Hu AND KAO  NeoSTX and STX Binding Sites 
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FIGURE 7.  Dose-response relations of STX, neoSTX, and constant ratio mixtures of the two 
toxins at pH 8.25. At this pH, N-1  -OH  of neoSTX is mostly deprotonated, with a  negatively 
charged oxygen. Conventions are similar to those in Fig. 6.  r  =  1.89.  Mixtures of a  ratio of 
~  1.8  are:  [neoSTX]/[STX]  =  5.4  nM/3 nM;  10.8/6;  16.2/9;  32.4/18.  Observed ED50 (as STX 
equivalent) fits the expected EDs0 for single-site action better than for two-site action, even with 
a  discrepancy of 32%. However, if the efficacy of neoSTX were 0.75 and that for STX were  1, 
then the observed EDs0 fits the expected EDs0 for the single-site case. See text for details. 
entirely valid.  However,  Eq.  3  in  Kao and Walker  (1982)  for the  case  of two  toxins 
acting on different sites can be replaced with the following relation,  which is, in fact, 
a  more general form: 
([T1]/K])(e ,  +  e2(xlr) 
f= 1  +  ([T,]/K0(1  +  a/r) 
TABLE  I 
Actions of Constant-Ratio Mixtures of STX and neoSTX 
A.  pH 6.50:  r = ED~0srx/EDso,~.~sTx = 3.58; ~ = [STX]/[neoSTX] = 3.5 
ED~0 (nM of neoSTX) 
Expected 
Observed 
One site  Two sites 
0.73 
B.  pH 8.25: 
0.74*  0.61" 
r = ED~0,.~a-x/ED~0,svx =  1.89; c~ = [neoSTX]/[STX] =  1.8 
EDso (nM of STX) 
Expected 
Observed 
One site  Two sites 
6.04  4.56*  3.78* 
6.05:  4.8U 
*Assuming efficacy is 1.0 for both STX and neoSTX. 
:Assuming efficacy is 0.75 for neoSTX and 1.0 for STX. 572  THE JOURNAL OF  GENERAL PHYSIOLOGY  •  VOLUME  97-  1991 
where el and ~2 are efficacies of toxins  1 and 2, respectively. For the results in pH 
8.25, if the efficacy of neoSTX were lowered to 0.75, and that of STX were kept at 1, 
then the  expected EDs0 closely approached  that  observed (Table I).  Further com- 
ments on this point follow in the Discussion. 
DISCUSSION 
Comparison with Earlier Work 
Because of the lack of specific chemical analytical methods for STX and  neoSTX, 
these  toxins  are  still  quantitated  by bioassay,  most  frequently the  mouse  lethality 
assay (e.g., Wichmann et al.,  1981). Absolute quantities are difficult to determine, but 
relative potencies with reference to that of STX are usually reliable and informative. 
The specific toxicity of STX (5,500 mouse units/rag of crystalline toxin) is generally 
agreed  on  by  different  investigators  in  the  field,  but  that  for  neoSTX  remains 
unsettled, with values from different laboratories differing by factors of ~ 2  (Hashi- 
moto and Noguchi,  1989). Previously, we found neoSTX to be equipotent with STX 
at pH  7.3  on the frog muscle fiber (Kao and Walker,  1982),  but  that  sample was 
obtained from a different source, and an independent assay suggested that it might 
have had a lower potency (Hall,  1982), which could account for the differences with 
the present results. 
In contrast to observations on isolated tissues, in mouse lethality bioassays almost 
all  investigators  who  have  purified  neoSTX  have  found  it  to  be  approximately 
equipotent with  STX (Genenah and  Shimizu,  1981; Wichmann  et al.,  1981;  Hall, 
1982;  Hashimoto and  Noguchi,  1989).  The discrepancy may be  explained by the 
following considerations. At  pH  7.4,  the  probable intraperitoneal  pH  of the  assay 
mouse, neoSTX is only 1.4 times more potent than STX (Fig. 5). As the precision of 
the bioassay is 20%, the difference in relative potencies of the two toxins might be too 
tenuous  to  be  determined  with  confidence.  It  is  also  possible  that  neoSTX  is 
converted to STX in the body (Shimizu and Yoshioka,  1981; Wichmann et al.,  1981) 
but not in isolated preparations of nerves and muscles, 
Possible Influence of Negative Charges in the Toxin-binding Site 
Recent studies using batrachotoxin-activated sodium channels incorporated into lipid 
bilayers  have  shown  the  presence  of a  higher  density  of negative  charges  in  the 
vicinity of the T-FX/STX binding  site  (Green et al.,  1987;  Guo et al.,  1987).  The 
density of these negative charges is influenced by pH, and can, in turn, influence the 
local concentration of the cationic STX and  neoSTX as well as T-I'X. The present 
results are based on equilibrium reactions that cannot easily differentiate between the 
effects of surface charges and those of specific charged groups in the toxin-binding 
site. However, our results show little evidence that these surface charges have been 
titrated to affect toxin binding between pH's 6.50 and 8.25. 
Concerning  the  specific  negative  charge  in  the  binding  site,  most  indications 
suggest that it has a pK~ of 5 or lower. In the present experiments, this group should 
be virtually fully ionized at pH 6.50, and would exert only minor incremental effects 
when pH was changed to 8.25. Although there is as yet rather meager information on 
details, we believe that this anionic group could be involved in the ion-pairing with Hu AND KAO  NeoSTX and STX Binding Sites  573 
the active guanidinium function (i.e., site a on Fig. 8) which we have identified as the 
7,  8,  9  group  in  STX  by  the  close relation  between  the  pH  dependencies  of its 
chemical state and  the potency. By analogy, we extended this identification to the 
7,  8,  9  guanidinium  in  neoSTX  because  we  beleive  that  by virtue  of their close 
structural similarities, including the C-12 -OH's common to both STX and neoSTX, 
the docking orientation of these molecules (Dean,  1989) for forming toxin-receptor 
complexes must  be very similar.  Thus,  the  N-1  -OH  of neoSTX is  probably not 
proximately involved in interacting with this specific negative charge in the binding 
site.  From these considerations we conclude that within the pH range of 6.50--8.25 
the main determinants of potency are the chemical state of the toxin molecule and 
the  abundance  of  the  active  species,  but  not  changes  in  the  receptor  or  the 
surrounding membrane. 
Influence  of the Chemical State of neoSTX on Its Reactivity 
In the Results we referred to an efficacy term (~) to explain some aspects of the action 
of neoSTX. In drug-receptor interactions,  the dose-response curves depend  on a 
combination of an affinity factor and  an efficacy factor (Ariens et al.,  1964;  Dean, 
1989).  We use  this  term in  a  general  sense  to embody the  meanings  of both  the 
"intrinsic activity" of Ariens (1954) and the "efficacy" of Stephenson (1956). Binding 
to the receptor does not automatically lead to the desired effect. Thus, a full agonist 
with an efficacy of 1 and a competetive antagonist with an efficacy of 0 could have the 
same affinity, but the agonist would produce the biological effect and the antagonist 
would not. In this and previous work, without probing into the detailed mechanisms 
between toxin binding and channel blockade, we have taken the simplest assumption 
that the efficacy factor is  1, meaning that during random collisions between the toxin 
molecules with  the  binding  sites,  each  collision  resulted  in  a  productive binding 
(Dean,  1989) which led to a blockade of the sodium channel. 
This assumption appears to be applicable to most instances shown in the Results, 
except that of neoSTX at pH 8.25. As shown in Table I, the only way for the observed 
results to fit a case of one-site action by both STX and neoSTX is if the efficacy of 
neoSTX were not 1 but 0.75. A plausible physical model for this situation is that only 
75% of the collisions of neoSTX with  the receptor site actually lead to productive 
binding  and  effective blockade  of the  sodium  channel.  Alternatively,  all  collisions 
might  lead  to  binding,  but  only  75%  of  the  binding  is  productive.  The  two 
possibilities might be distinguished  by kinetic studies,  in isolated systems, of diffu- 
sional or post-collisional delays and the rates of association and dissociation, but not 
by the equilibrium studies we have done in the present experiments. In either case, 
neoSTX  at  pH  8.25  could  behave  somewhat  like  a  partial  agonist  under  some 
conditions, but differ from it in being capable of blocking all INa at high concentra- 
tions. Experimentally, we have seen that at 10-20 times the EDs0, neoSTX at pH 8.25 
can block all IN, (Yang,  L.,  and  C.  Y.  Kao, unpublished  observations). Perhaps for 
neoSTX the form with a  protonated N-1  -OH  is the channel-blocking species and 
the  form  with  a  deprotonated  N-1  -O-  is  an  ineffective  species.  Whether  the 
ineffectiveness is due to low affinity or to incorrect docking orientation remains to be 
investigated.  Nevertheless,  the  possibility  of the  coexistence  of an  active  and  an 
inactive species, with the resultant competition for the binding site,  could underlie 574  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  97  •  1991 
the shortfall between the observed and expected potencies of neoSTX at pH  8.25 
(Fig. 5). 
Implications for the Structure of the Binding  Site 
In the surface-receptor hypothesis, STX is viewed as binding to some site very close 
to the external orifice of the sodium channel by the  side of the molecule with the 
C-12  -OH  groups  (Kao  and  Walker,  1982;  Kao,  1983).  Because  the  1,  2,  3 
guandinium group is located on the opposite side of the molecule, it was considered 
not to be directly involved in blocking the channel. 
NeoSTX  is  most  active  and  more  potent  than  STX  when  the  N-1  group  is 
protonated with no charge. It is least active and less potent than STX when the N-1 
group is deprotonated with a negatively charged oxygen. A possible explanation for 
•  FIGURE 8.  Perspective view of 
(~,or~  neoSTX and probable binding 
"0,'/  site points in the sodium chan- 
nel. Sites a-c have been identi- 
0  fled  previously  (Kao  and 
,NHt  Walker,  1982; Kao,  1983); site 
~~  a, probably an ionized carboxy- 
late  function,  ion-pairs  with 
O~  NHz'"  the 7,  8, 9 guanidinium,  while 
/  /~,o~  ~  sites b and c, as carboxylates or 
H..  5  0  H,,N~N'~4  |  other hydrogen-accepter func- 
,~-'~N~"--  \  l  lions,  form  hydrogen  bonds 
o  ,  ,"  with the C-12 -OH's. Site d is 
9  O~  newly identified  by the present 
results.  Probably  an  ionized 
0  carboxylate  function,  it  inter- 
/  acts with N-I -OH of neoSTX, 
hydrogen-bonding  while  the 
c  ;  ,  group  is  protonated,  and 
o~  L--j  charge-repelling  when  the 
x  ~  group is deprotonated. 
these  observations  is  that  the  N-1  -OH  lies  close  to  an  anionic  function  in  the 
sodium  channel  protein,  with  which  it  can  form  a  hydrogen  bond  when  in  the 
protonated state, and by which it is repelled when in the deprotonated state. In Fig. 
8, which  illustrates  this  view,  site a  probably ion-pairs with  the  positively charged 
active guanidinium group. Sites b and c form hydrogen bonds with the C-12  -OH's. 
The present results suggest that site d can form a hydrogen bond with or repel the 
N-I  -OH  of neoSTX. Sites a and d are probably deprotonated carboxylate functions 
in the sodium channel protein, whereas sites b and c could be similar groups or other 
hydrogen accepter functions. As these site points (Dean,  1989) practically envelope 
the toxin molecule, the  total toxin-binding  site is  not likely to be planar  over the 
dimensions of the toxin molecule, but is probably in a pocket or crevice of the sodium 
channel protein. Hu AND KAO  NeoSTX and STX Binding Sites  575 
Such a possibility escaped detection before, when only STX was studied. Neverthe- 
less, if this structural detail of the binding site were to be valid for neoSTX, it has to 
be valid  for STX as well.  In  STX,  the  1,  2,  3  guanidinium with  a  pI~  of 11.2  is 
completely protonated within the physiological range of pH's. Whether the positive 
charge on this group has any influence on the binding of the whole toxin molecule is 
unknown,  but it could exert a  constant influence that would  not be detectable by 
limited changes of pH. However, the possibility that neoSTX interacts differently, as 
does STX, could explain the higher potency of neoSTX at some pH's, and its lower 
potency at other pH's. This proposed mechanism is consistent with an observation 
that the dissociation rate constant for neoSTX is lower than that for STX on sodium 
channels  incorporated  in  lipid  bilayers  at  pH  7.4  (Moczydlowski  et  al.,  1984b). 
Indeed,  one  might  expect  the  dissociation  rate  constant  for  neoSTX  to  be  pH 
dependent. Perhaps an "aUosteric" mechanism of action of STX (Green et al.,  1987) 
can also be explained, as blockage of access to a crevice could occur some distance 
away from the actual permeation path of the sodium channel. 
Critique  of Strichartz's  Covalent-Bonding Hypothesis 
Because he found neoSTX to be four to eight  times more potent  than  STX,  and 
because  the  C-11  protons  in  neoSTX exchanged more rapidly  as  compared with 
those in STX, Strichartz (1984) concluded that the two phenomena can be linked by 
the  presence  of a  larger  fraction  of a  carbonyl  function  at  the  C-12  position  in 
neoSTX  than  in  STX.  He  proposed  a  two-step  mechanism  by  which  STX  first 
attached  to  the  receptor by  ion-pairing  through  the  7,  8,  9  guanidinium,  and  a 
subsequent  dehydration  of the  C-12  gem-diol  to  the  carbonyl  form,  which  then 
formed a  Schiff-base covalent bond with  a  secondary amine  or an  oxygen in  the 
receptor. 
This covalent mechanism differs substantially from another suggested mechanism 
by which the C-12  -OH  groups attach to the receptor site through hydrogen bonds 
(Koehn et al., 1981; Kao and Walker, 1982; Kao, 1983; Kao et al., 1985). Because the 
primary structure of the sodium channel is known (Noda et al.,  1984), these different 
suggestions could place the STX-binding site,  and  probably also the mouth of the 
sodium  channel,  in  quite  different parts  of the  channel  protein.  Therefore,  it  is 
worthwhile to consider Strichartz's proposed mechanism in some detail. 
Aside  from the  fact that  he  relied entirely on  changes  in  the  compound  action 
potentials of multifiber nerve bundles,  Strichartz did not consider some important 
chemical  properties  of  the  toxin  molecules.  An  important  test  of  his  covalent 
hypothesis is to know whether neoSTX, when reduced at the C-12  position, would 
still be active. This test would parallel the situation known for STX. When either one 
of the  C-12  -OH's  in  STX  is  reduced,  alcohol  functions  result  that,  energically, 
cannot  form  covalent  bonds.  Yet  the  reduced  compounds,  saxitoxinols,  possess 
intrinsic activity, even through it is much less than that of STX (Koehn et al.,  1981; 
Kao and Walker,  1982; Strichartz,  1984;  Kao et al.,  1985). We suggested that both 
C-12 -OH  functions probably formed hydrogen bonds with acceptors in the receptor 
site (sites b and c in Fig. 8). 
NeoSTX has been reduced to neosaxitoxinol by Wichmann (1981), who found it to 
be weakly active. The relative potency of neosaxitoxinol to neoSTX is  comparable 576  THE JOURNAL OF  GENERAL PHYSIOLOGY • VOLUME 97 • 1991 
with that of saxitoxinol to STX. Since the C-12  groups in neosaxitoxinol are in an 
alcohol configuration that cannot form covalent bonds, the intrinsic activity must be 
attributed  to some noncovalent mechanism.  In neoSTX the C-I 2  groups  probably 
participate in hydrogen bonding in a similar manner as in STX. 
Trinitrobenzenesulfonic acid, an amino-modifying reagent, which Strichartz (I 984) 
and his co-workers (1984) found to interfere with the binding of [aH]STX, also did 
not affect the reduction of INa by STX or TIX  in voltage-clamped preparations of 
either frog nerves or muscles (Pappone,  1986). 
From these considerations, we conclude that the participation of the N-I  -OH  of 
neoSTX in  binding  to  the  receptor is  sufficient to account for the  slightly higher 
potency of neoSTX  over that  of STX  in  acidic  and  neutral  pH's.  Our  proposed 
mechanisms  has  the  added  advantage  of explaining  the  weakness  of neoSTX  in 
alkaline  pH's,  an  observation  that  cannot  be  explained  by  Strichartz's  covalent 
mechanism. 
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